Evidence map›Paper›PMID 30943378›Full record

ArticleAnalytical biochemistry2019

Development of an HPLC-based guanosine monophosphate kinase assay and application to Plasmodium vivax guanylate kinase.

Liliana Pedro, Megan Cross, Andreas Hofmann, Tin Mak, Ronald J Quinn

Open access · hybridAbstract read
In one paragraph

Article in Analytical biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of GMPP fromOpen life sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Liliana PedroGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
Megan CrossGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
Andreas HofmannGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
Tin MakGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
Ronald J QuinnGriffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia. Electronic address: r.quinn@griffith.edu.au.
Griffith University · AU

Funding

Structural Genomics of Pathogenic ProtozoaP50GM064655 · NIGMS · UNIVERSITY OF WASHINGTON · PI HOL, WILHELMUS G. J. · 2001 to 2004
$25.3M
NIGMS NIH HHS P50 GM064655
6 · The paper itself

Abstract

The development of a high-performance liquid chromatography (HPLC)-based method, for guanosine monophosphate kinase activity assays, is presented. The method uses the intrinsic UV absorption (at 260 nm) of substrates and products of the enzymatic reaction (GMP, ATP, ADP and GDP) to unambiguously determine percent conversion of substrate into product. It uses a commercially available C18 column which can separate reaction samples by elution under isocratic conditions in 12 min per run. The kinetics of the forward reaction catalyzed by Plasmodium vivax guanylate kinase (PvGK), a potential drug target against malaria, was determined. The relative concentrations of the two substrates (GMP and ATP) have a distinct effect on reaction velocity. Kinetic analyses showed the PvGK-catalyzed reaction to be associated with atypical kinetics, where substrate inhibition kinetics and non-Michaelis-Menten (sigmoidal) kinetics were found with respect to GMP and ATP, respectively. Additionally, the method was used in inhibition assays to screen twenty fragment-like compounds. The assays were robust and reproducible, with a signal window of 3.8 and a Z' factor of 0.6. For the best inhibitor, an IC

Indexed as

AnimalsCatalysisChromatography, High Pressure LiquidGuanylate KinasesKineticsPhosphorylationPlasmodium vivaxGuanylate KinasesGuanosine monophosphate kinaseGuanylate kinaseHPLCNucleotideSigmoidal kineticsSubstrate inhibition

Identifiers

PMID30943378
PMCPMC6494078
OpenAlexW2932626212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.